Targeting ATP-citrate lyase across cardiometabolic and oncologic disease

PHARMACOLOGICAL RESEARCH · Published 2026-07-20 · DOI 10.1016/j.phrs.2026.108348

Free full text

Authors (7)

Chiara Macchi, Silvia Pedretti, Serena Ghisletti, Alberto Corsini, Nico Mitro, Cesare R. Sirtori, Massimiliano Ruscica

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Macchi, C., Pedretti, S., Ghisletti, S., et al. (2026). Targeting ATP-citrate lyase across cardiometabolic and oncologic disease. PHARMACOLOGICAL RESEARCH. https://doi.org/10.1016/j.phrs.2026.108348

Related articles

• A multi-component intervention enhances intestinal urate excretion and improves metabolic and immune homeostasis in diet-induced hyperuricemia · PHARMACOLOGICAL RESEARCH · 2026 · Same journal
• Targeting pulmonary vascular–alveolar coupling in bronchopulmonary dysplasia: Therapeutic mechanisms and translational prospects of extracellular vesicle-based drug delivery · PHARMACOLOGICAL RESEARCH · 2026 · Same journal
• Targeting RNA quality-control defects in tauopathies: Pharmacodynamic biomarkers and therapeutic development · PHARMACOLOGICAL RESEARCH · 2026 · Same journal
• Neural and behavioral dynamics of acute fentanyl administration and implications for hazard assessment of novel synthetic opioids in larval zebrafish · PHARMACOLOGICAL RESEARCH · 2026 · Same journal
• Artesunate as an emerging anticancer modality: Insights and advances · PHARMACOLOGICAL RESEARCH · 2026 · Same journal
• Harnessing edible extracellular vesicles for inflammatory bowel disease: From natural immunomodulators to bioengineered oral nanotherapeutics · PHARMACOLOGICAL RESEARCH · 2026 · Same journal
• Innate immune surveillance and nucleic acid sensing: Gatekeepers of inflammatory cell death in respiratory infectious diseases · PHARMACOLOGICAL RESEARCH · 2026 · Same journal
• Sinomenine regulates the AKT/FOXO3/GLUL pathway to inhibit pulmonary fibroblast-to-myofibroblast transition via α7nAChR against rheumatoid arthritis associated interstitial lung disease · PHARMACOLOGICAL RESEARCH · 2026 · Same journal
• The regulatory mechanisms of Indole-3-carboxaldehyde in immune cells and its role in autoimmune diseases · PHARMACOLOGICAL RESEARCH · 2026 · Same journal
• Phagocytosis by brain macrophages in central nervous system diseases: Dual effects, cellular heterogeneity, and targeted therapeutic strategies · PHARMACOLOGICAL RESEARCH · 2026 · Same journal